Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion

Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1277-82.

Abstract

Aims: To determine the influence of recommended therapeutic doses of pantoprazole and omeprazole on meal-stimulated acid secretion.

Methods: In this double-blind, placebo-controlled, three-period crossover study, 12 healthy male volunteers received 40 mg pantoprazole od, 20 mg omeprazole od or placebo at 08:00 h for 5 days in a randomized order. Meal-stimulated acid secretion was determined by means of a homogenized test meal, and intragastric titration on day 1, 4-6 h, 8-10 h, 16-18 h, and 24-26 h, and on days 3 and 5, 4-6 h after oral drug administration.

Results: On day 1 (4-6 h after oral drug administration), meal-stimulated acid secretion was decreased by 36% and 24% after administration of 40 mg pantoprazole or 20 mg omeprazole, respectively. After 3 and 5 days of dosing, the decreases were 88% and 85% with 40 mg pantoprazole, and 70% and 74% with 20 mg omeprazole. At all measuring points during the 5-day dosing periods, 40 mg pantoprazole proved superior to 20 mg omeprazole in inhibiting meal-stimulated gastric acid secretion. The differences were statistically significant for pantoprazole on day 1, 24-26 h after oral drug administration and on day 3 (P = 0.0425 and P = 0.0244, respectively). On day 1, only pantoprazole was significantly better than placebo (P = 0.0210, 4-6 h after dosing; P = 0.0093, 8-10 h after dosing and P = 0.0068, 16-18 h after dosing).

Conclusion: Pantoprazole 40 mg is significantly more effective than omeprazole 20 mg in inhibiting meal-stimulated acid secretion. In addition, pantoprazole exhibits a more rapid onset of action.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Anti-Ulcer Agents / adverse effects
  • Anti-Ulcer Agents / pharmacology*
  • Benzimidazoles / adverse effects
  • Benzimidazoles / pharmacology*
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Gastric Acid / metabolism*
  • Gastric Acidity Determination
  • Gastric Mucosa / drug effects*
  • Gastric Mucosa / physiology
  • Humans
  • Male
  • Omeprazole / adverse effects
  • Omeprazole / pharmacology*
  • Pantoprazole
  • Postprandial Period
  • Proton Pump Inhibitors
  • Random Allocation
  • Sulfoxides / adverse effects
  • Sulfoxides / pharmacology*
  • Time Factors

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Benzimidazoles
  • Proton Pump Inhibitors
  • Sulfoxides
  • Pantoprazole
  • Omeprazole